Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MicroRNAs as a clue to overcome breast cancer treatment resistance
Iris Garrido‐Cano, B. Pattanayak, Anna Adam‐Artigues, et al.
Cancer and Metastasis Reviews (2021) Vol. 41, Iss. 1, pp. 77-105
Open Access | Times Cited: 22

Showing 22 citing articles:

The role of miRNAs as biomarkers in breast cancer
Temesgen Baylie, Mulugeta Kasaw, Mamaru Getinet, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 8
Delivery of miR-200c-3p Using Tumor-Targeted Mesoporous Silica Nanoparticles for Breast Cancer Therapy
Iris Garrido‐Cano, Anna Adam‐Artigues, Ana Lameirinhas, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 32, pp. 38323-38334
Open Access | Times Cited: 20
miR-146a-5p Promotes Angiogenesis and Confers Trastuzumab Resistance in HER2+ Breast Cancer
P. Cabello, Sandra Torres-Ruiz, Anna Adam‐Artigues, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 2138-2138
Open Access | Times Cited: 11
Hypoxia-Inducible Factor-Dependent and Independent Mechanisms Underlying Chemoresistance of Hypoxic Cancer Cells
Peter Wai Tik Lee, Lina Rochelle Koseki, Takao Haitani, et al.
Cancers (2024) Vol. 16, Iss. 9, pp. 1729-1729
Open Access | Times Cited: 4
Unraveling the Role of microRNAs in the Metastatic Landscape of Gastric Cancer
Arefeh Zabeti Touchaei, Sogand Vahidi
(2025) Vol. 2, Iss. 1, pp. 105-118
Closed Access
PTEN-Mediated Resistance in Cancer: From Foundation to Future Therapies
Muhammad Tufail
Toxicology Reports (2025) Vol. 14, pp. 101987-101987
Open Access
miRNAs as emerging predictors of tamoxifen resistance in breast cancer
Elmira Aboutalebi Vand Beilankouhi, Reza Safaralizadeh, Babak Nejati, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Involvement of microRNAs-449/FASN axis in response to trastuzumab therapy in HER2-positive breast cancer
Ana Lameirinhas, Sandra Torres‐Ruiz, Iris Garrido‐Cano, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access
MicroRNAs as Endocrine Modulators of Breast Cancer
Vinitha Richard, Kevin Lee, Michael Joseph Kerin
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3449-3449
Open Access
MiR-181c suppresses triple-negative breast cancer tumorigenesis by targeting MAP4K4
Dan Xie, Saiyang Li, Tianqi Wu, et al.
Pathology - Research and Practice (2022) Vol. 230, pp. 153763-153763
Closed Access | Times Cited: 18
miRNA Expression Profiling in Human Breast Cancer Diagnostics and Therapy
Iga Dziechciowska, Małgorzata Dąbrowska, Anna Mizielska, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 12, pp. 9500-9525
Open Access | Times Cited: 8
Restoring microRNA-34a overcomes acquired drug resistance and disease progression in human breast cancer cell lines via suppressing the ABCC1 gene
Shaymaa M.M. Yahya, Heba K. Nabih, Ghada H. Elsayed, et al.
Breast Cancer Research and Treatment (2023) Vol. 204, Iss. 1, pp. 133-149
Open Access | Times Cited: 8
Regulation of Inflammasome by microRNAs in Triple-Negative Breast Cancer: New Opportunities for Therapy
Liliana-Roxana Balahura, Sorina Dinescu, Marieta Costache
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3245-3245
Open Access | Times Cited: 7
Cancer drug resistance related microRNAs: recent advances in detection methods
Xinyuan Hu, Zhen Song, Zi-Wei Yang, et al.
The Analyst (2022) Vol. 147, Iss. 12, pp. 2615-2632
Closed Access | Times Cited: 11
Restoration of Altered Oncogenic and Tumor Suppressor microRNA Expression in Breast Cancer and Colorectal Cancer Cell using Epicatechin
Sheetal Kiran, Abhilipsa Patra, Poonam Verma, et al.
Current Molecular Pharmacology (2023) Vol. 16, Iss. 8
Closed Access | Times Cited: 4
Circulating miR-221/222 expression as microRNA biomarker predicting tamoxifen treatment outcome: a case–control study
Ilhamjaya Patellongi, Alfiah Amiruddin, Muhammad Nasrum Massi, et al.
Annals of Medicine and Surgery (2023) Vol. 85, Iss. 8, pp. 3806-3815
Open Access | Times Cited: 4
The role of circRNAs and miRNAs in drug resistance and targeted therapy responses in breast cancer
Meilan Zhang, Zhaokuan Zheng, Shouliang Wang, et al.
Cancer Drug Resistance (2024)
Open Access | Times Cited: 1
Long non‐coding RNAs regulate treatment outcome in leukemia: What have we learnt recently?
Huiping Shi, Liang Gao, Weili Zhang, et al.
Cancer Medicine (2023) Vol. 12, Iss. 13, pp. 13966-13977
Open Access | Times Cited: 3
Use of Gain-of-Function Screening to Identify miRNAs Involved in Paclitaxel Resistance in Triple-Negative Breast Cancer
Stéphane Nemours, Carla Solé, Ibai Goicoechea, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13630-13630
Open Access
MiRNAs as Promising Therapeutic Targets for Breast Cancer
Morkoss Fakhry, Asmaa R. Abdel-Hamed, Noha M. Mesbah, et al.
OBM Genetics (2024) Vol. 08, Iss. 01, pp. 1-27
Open Access
miRNA therapeutics in precision oncology: a natural premium to nurture
Chakresh Kumar Jain, Poornima Srivastava, Amit Kumar Pandey, et al.
Exploration of Targeted Anti-tumor Therapy (2022), pp. 511-532
Open Access | Times Cited: 2
WITHDRAWN: Mechanism of the microRNA-4677-3p/LDHB axis in the regulation of paclitaxel resistance of breast cancer cells
Ying Chen, Qinzuo Dong, Liwei Xing, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top